InsidersTradesSigma
Follow the IMMURON LIMITED stock price and the full insider trade history of the company, a publicly traded company based in Australia. Shares trade on the AU market, under the supervision of ASX. Market capitalisation: €11m. The latest transaction was disclosed on 15 July 2026 (Change in Substantial Holding). Among the most active insiders: listed in Annexure A (Group Entity),(together BNY Group). Every trade is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
IMMURON LIMITED 是一家在澳大利亚证券交易所上市的公司，专注于开发肠道疾病治疗方法。该公司强调在医疗保健领域进行研究和创新。